EFT BioTech Holdings Inc. Selects Auditors; Signs Engagement Letter for Audited Financials

EFT BioTech Holdings Inc. (PINKSHEETS: EFTB), today announced that it has retained the services of Weinberg & Company, P.A., as independent auditors for the Company.

Weinberg & Company, P.A. has offices in Florida, California, and Hong Kong providing audit services to public and private companies worldwide. Weinberg & Company has been ranked #40 among America's Top 100 Auditors by Who Audits America. In addition, the Firm ranks second among the top five firms headquartered in the South Florida and Los Angeles marketplace. Weinberg & Company, P.A. has undergone peer review performed by an AICPA approved CPA firm, a member of the AICPA Division of Firms SEC and Private Companies Practices Sections, and is registered with the Public Company Accounting Oversight Board.

EFT BioTech Holdings Inc.'s Chairman and President, Jack Qin, commented, "After an intensive and focused effort, we are pleased to have retained such a prestigious firm as Weinberg & Company as independent auditors for EFT BioTech. We believe their expertise, professionalism, and most importantly, their focus and experience with fully reporting global companies, will serve EFT BioTech and its shareholders well."

About EFT BioTech Holdings Inc.

EFT BioTech Holdings Inc. is a very unique E-Business Company designed around the concept of Business-to-Customer using the World Wide Web as our "storefront" and business platform. EFT's method of conducting business is for a customer to go online and join EFT as an Affiliate. Once the customer completes the necessary information for joining EFT, selects and pays for his/her order, he/she is then considered as an EFT Affiliate. From that time on, the Affiliate is allowed to receive a commission on the purchases made by others who he/she introduces to EFT and also on additional Affiliates who his/her Affiliate introduces to the EFT. EFT's website is www.ef2t.com .

Safe Harbor for Forward-Looking Statements

Statements made in this release with the respect to the Company's current plans, estimates, strategies and beliefs and other statements that are not historical are forward-looking statements. Forward-looking statements include, but are not limited to, those statements using words such as "believe," "expect," "plans," "strategy," prospects," "forecast," "estimate," "project," "anticipate," "aim," "may" or "might" and words of similar meaning in connection with a discussion of future operations, financial performance, vents or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management's assumptions and belief in light of the information currently available to it. The company cautions you that a number of important risks and uncertainties could cause actual results to materially differ from those discussed in the forward-looking statements, and therefore, you should not play undue reliance on them. You also should not rely on any obligation of the Company to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The company disclaims any such obligation unless required by law. Risks and uncertainties that might affect the Company include, but are not limited to (i) the global economic environment in which the Company operates, as well as the economic conditions in the Company's markets, (ii) levels of consumer spending, and (iii) exchange rates, particularly between the Chinese Yen and the U.S. Dollar. Risks and uncertainties also include the impact of any future events with material adverse impacts.

Contact: Tony K. So EFT BioTech Holdings, Inc. Phone: (852) 9150 2104 626-581-0388 USA 852-3514-4113 Hong Kong